Clinical Trials Browser

Glioma × Bevacizumab × Lymphoid × Clear all

NCT01954030 2016-02-19

Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure

Phase 1 Terminated

Glioma, Lymphoma, Follicular